Genworth Financial Inc (GNW)

GNW (NYSE:Insurance) EQUITY
$3.25
pos +0.39
+14.00%
Today's Range: 3.16 - 3.48 | GNW Avg Daily Volume: 8,261,900
Last Update: 04/29/16 - 2:12 PM EDT
Volume: 14,637,897
YTD Performance: -23.32%
Open: $3.21
Previous Close: $2.86
52 Week Range: $1.57 - $9.19
Oustanding Shares: 497,828,731
Market Cap: 1,468,594,756
6-Month Chart
TheStreet Ratings Grade for GNW
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 1 1 1 1
Moderate Buy 1 1 1 1
Hold 5 5 5 5
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 2.88 2.88 2.88 2.88
Latest Dividend: 0.10
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 10/08/08
Price Earnings Ratio: -7.02
Price Earnings Comparisons:
GNW Sector Avg. S&P 500
-7.02 0.00 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
9.16% -64.21% -71.02%
GROWTH 12 Mo 3 Yr CAGR
Revenue -10.60 -0.10 -0.05
Net Income 0.00 -1.00 0.00
EPS 0.00 -2.90 0.00
Earnings for GNW:
EBITDA 0.40B
Revenue 8.55B
Average Earnings Estimates
Qtr (06/16) Qtr (09/16) FY (12/16) FY (12/17)
Average Estimate $0.20 $0.20 $0.76 $0.94
Number of Analysts 3 3 3 3
High Estimate $0.23 $0.22 $0.80 $0.95
Low Estimate $0.16 $0.17 $0.71 $0.91
Prior Year $0.24 $0.13 $0.51 $0.76
Growth Rate (Year over Year) -15.28% 56.41% 49.67% 22.71%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
A new annuity product could help ailing Genworth, but the company's debt burden looms. 
Three stocks that could be had for $2 and two stocks that can now be had for $3 -- though you may not want them.
Insurance company announces internal restructuring, then credit is downgraded, then stock falls.
On a tough trading day, some of 2015's biggest losers were winners.
Will 2016 be the year that Genworth Financial is no longer able to sell bogus reassurances that everything will be OK in long-term care?
Borrowing seemed like a good idea at the time. It wasn't.
How higher interest rates will impact RDN's core private-mortgage-insurance business. What business mix the company expects in 2016 between refinancings and new insurance. (PMI use is almost 4x higher with new mortgages vs refinancings.) A general discussion of the competitive landscape -- more specifically, a profile of industry pricing, as well as Radian's response and the impact on profitability if discounting increases. The broader outlook for PMI demand -- how large the business pipeline is, and whether the company expects to
It is possible that the worst has already happened.

Columnist Conversations

The Biotech iShares (IBB) ETF has broken through support at the $270.00 level and is testing its 50 day moving...
I bought some more shares of Interface (TILE) just now at $16.95. TILE looks good for a move into the $23 - $...
Biotech is having a very tough day, as investors react to the first miss in 9 quarters from Gilead Sciences (G...
1. Unmasking Zero Hedge 2. Tech as In Wreck (I really think this is a good column , at least I enjoyed writing...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.